Luwy Musey Selected Research

23-valent pneumococcal capsular polysaccharide vaccine

3/2022	Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).
10/2021	Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH).
1/2021	Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.
1/2021	Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.
1/2018	Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly.
1/2016	Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luwy Musey Research Topics

Disease

6	Pneumococcal Infections 03/2022 - 01/2016
4	Infections 12/2019 - 07/2003
3	Pain (Aches) 03/2022 - 10/2021
1	Fatigue 03/2022
1	Pneumococcal Pneumonia 01/2021
1	Virus Diseases (Viral Diseases) 12/2019
1	Spontaneous Abortion (Miscarriage) 12/2019
1	Measles 01/2016
1	Rubella (German Measles) 01/2016
1	Mumps 01/2016
1	Neoplasms (Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

6	23-valent pneumococcal capsular polysaccharide vaccineIBA 03/2022 - 01/2016
6	VaccinesIBA 01/2022 - 07/2003
2	Conjugate VaccinesIBA 03/2022 - 10/2021
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2021 - 01/2021
2	AntigensIBA 05/2009 - 09/2003
1	Polysaccharides (Glycans)IBA 01/2021
1	Cytomegalovirus VaccinesIBA 12/2019
1	AntibodiesIBA 12/2019
1	Viral AntigensIBA 12/2019
1	Neutralizing AntibodiesIBA 01/2019
1	EnzymesIBA 01/2016
1	Rubella VaccineIBA 01/2016
1	ImmunosorbentsIBA 01/2016

Therapy/Procedure

1	Therapeutics 05/2009
1	Immunotherapy 05/2009